Evidence map›Paper›PMID 26512045›Full record

ReviewThe oncologist2015

Distance as a Barrier to Cancer Diagnosis and Treatment: Review of the Literature.

Massimo Ambroggi, Claudia Biasini, Cinzia Del Giovane, Fabio Fornari, Luigi Cavanna

Abstract readReview
In one paragraph

Review in The oncologist, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 295 papers, 8 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
295citing papers in PubMed, 8 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

295 citing papers in PubMed, 8 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. The Impact of Travel Distance on Cancer Stage at Diagnosis for Cancer: A Systematic Review.International journal of environmental research and public health · 2025
    Pooled it
  4. Pooled it
  5. A systematic review on the qualitative experiences of people living with lung cancer in rural areas.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2024
    Pooled it
  6. Patients' perspectives on the relevance of biosimilars' outcomes in oncology: qualitative study with nominal group technique.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2023
    Pooled it
  7. Pooled it
  8. Financial toxicity of cancer care in low- and middle-income countries: a systematic review and meta-analysis.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2022
    Pooled it
  9. Trial
  10. A stepped-care approach to self-management: a qualitative study among individuals with cancer and their caregivers using the Coping-Together program.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2025
    Trial
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

235 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Massimo AmbroggiDepartment of Oncology-Hematology, G. da Saliceto Hospital, Piacenza, Italy.
Claudia BiasiniDepartment of Oncology-Hematology, G. da Saliceto Hospital, Piacenza, Italy.
Cinzia Del GiovaneDepartment of Diagnostic, Clinical and Public Health Medicine, University of Modena and Reggio Emilia, Modena, Italy.
Fabio FornariDepartment of Medicine, G. da Saliceto Hospital, Piacenza, Italy.
Luigi CavannaDepartment of Oncology-Hematology, G. da Saliceto Hospital, Piacenza, Italy l.cavanna@ausl.pc.it.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The burden of travel from a patient's residence to health care providers is an important issue that can influence access to diagnosis and treatment of cancer. Although several studies have shown that the travel burden can result in delays in diagnosis and treatment of many common cancers, its role appears underestimated in the treatment of patients in clinical practice. Therefore, we performed a review of the published data on the role of travel burden influencing four items: delay of diagnosis, adequate treatment of cancer, outcome, and quality of life of cancer patients. Forty-seven studies published up to December 2014 were initially identified. Twenty studies were excluded because they did not regard specifically the four items of our review. Twenty-seven studies formed the basis of our study and involved 716,153 patients. The associations between travel burden and (a) cancer stage at diagnosis (12 studies), (b) appropriate treatment (8 studies), (c) outcome (4 studies), and (d) quality of life (1 study) are reported. In addition, in two studies, the relation between travel burden and compliance with treatment was examined. The results of our review show that increasing travel requirements are associated with more advanced disease at diagnosis, inappropriate treatment, a worse prognosis, and a worse quality of life. These results suggest that clinical oncologists should remember the specific travel burden problem for cancer patients, who often need health care services every week or every month for many years.

Indexed as

Health Services AccessibilityFemaleHumansMaleNeoplasmsQuality of LifeTreatment OutcomeCancer diagnosis and treatmentCancer patientsDistance from hospitalsOutcomeQuality of lifeTravel burden

Identifiers

PMID26512045
PMCPMC4679078

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.